Found 6 matching trials
AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
N/AThe goal of this observational study is to extract the imaging features of ...
Location
Shanghai Cancer center
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC
N/AThe goal of this observational study is to explore the feasibility of stere...
Location
Wuhan Tongji Hospital
RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations
PHASE2Disitamab Vedotin(RC48)combined with EGFR or HER2 TKIs in locally advanced ...
Location
Multiple Locations
Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study
NAThe goal of this clinical trial is to explore the efficacy and safety of do...
Location
The Second Affiliated Hospital of Nanchang University
Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.
PHASE2This study evaluated the efficacy and safety of gumarontinib combined with ...
Location
Multiple Locations
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC:Prospective Study
PHASE4This is a nationwide, multicenter and prospective cohort study. The purpose...
Location
Affiliated Hospital of Nantong University